Latest news for health professionals

Featured in this feed are the latest news, blogs and case studies written for health and social care professionals working with people affected by MS.

Topics covered include everything from service development to care for people with advanced MS, from use of technology in MS care to career development for MS specialists. Would you like to write a blog for us? Do you have any ideas for topics you'd like to see? Get in touch and let us know!

International Nurses' Day

International Nurses' Day is on 12 May this year. we take a moment to recognise not only the skill and dedication of nurses working in neurology, but also the generosity with which they share knowledge, support one another and lead improvement in care.

12 February 2026

New specialist MS Nurse in North West London

MS Trust and London Northwest University Healthcare NHS Trust are pleased to announce that they have appointed a new specialist MS nurse, Jero Esplanada. This role will be vital in enhancing support for people living with multiple sclerosis across the region.

19 November 2025

MS Trust welcomes new Director of Services

MS Trust are delighted to announce that Ruth Stross has been appointed as the new Director of Services at MS Trust.

29 October 2025

New guidelines for rehabilitation in chronic neurological conditions

The National Institute for Health and Care Excellence (NICE) have published new guidelines on rehabilitation for people with conditions like MS, motor neurone disease and Parkinson's disease.

14 July 2025

New guidance for intermittent catheters

NICE published updated guidance on the prescribing of intermittent catheters, endorsing the importance of choice, comfort and ease of use, and the reduction of UTIs.

3 July 2025

What next for the Universal Credit and PIP bill?

As the Universal Credit and Personal Independence Bill progresses through Parliament, we look at what's new.

27 May 2025

Tolebrutinib slows down disability progression in non-relapsing secondary progressive MS

Results from a phase III clinical trial show that tolebrutinib can significantly slow down disability progression in people with secondary progressive MS who no longer experience relapses.